Fiducial markers in adjuvant setting for a patient affected by endometrial cancer: a case report.

IGRT (image guided radiation therapy) adjuvant treatment endometrial cancer fiducial marker (FM) radiotherapy

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 26 02 2023
accepted: 04 08 2023
medline: 15 9 2023
pubmed: 15 9 2023
entrez: 15 9 2023
Statut: epublish

Résumé

Intermediate-high and high-risk endometrial cancer often require adjuvant treatments such as radiotherapy (RT) or brachitherapy (BT) to reduce the risk of loco-regional relapse. Inter- and intra-fraction variability of internal pelvic anatomy are possibly the largest source of error affecting pelvic RT. The implantation of Fiducial Makers (FMs) in the vaginal cuff of patients receiving RT or BT could help patient daily setup, image guidance and intra-fraction detection of the radiation targets. We have evaluated the case of an 80-year-old woman treated with surgery for endometrioid adenocarcinoma G2 (stage pT1b Nx LVSI+) who underwent adjuvant pelvic IMRT after the implantation of vaginal cuff FMs. Patient underwent planning CT scan 10 days after FMs implantation. RT consisted of 45Gy in 25 daily fractions to pelvic lymph nodes and surgical bed with simultaneous integrated boost up to 52.5Gy to the vaginal cuff and the upper two-thirds of the vagina. Cone beam Computed Tomography (CBCT) was acquired prior to every RT fraction for IGRT. Bladder and rectum were re-contoured on every CBCTs. Bladder and rectal volumes and median shifts were reported on a prospective database to quantify the impact of the pelvic organ variations. The patient reported no discomfort during the FMs implantation, and no complications were seen. No evidence of FMs migration was reported. Bladder and rectal volumes planned contours were 245 and 55.3cc. Median bladder volumes for approved and "not acceptable" CBCTs were 222cc (range: 130-398) and 131cc (range: 65-326), respectively. Median rectal volumes for approved and "not acceptable" CBCTs were 75cc (range: 58-117) and 90cc (range: 54-189), respectively. The median values of the anterior-posterior, superior-inferior, lateral direction shifts were 3.4, 1.8 and 2.11 mm, respectively. In our clinical case, the implantation of FMs in the vaginal cuff of a patient who underwent pelvic adjuvant RT was well tolerated and reported no complications. The use of IGRT procedures based on FMs surrogating the vaginal vault may reduce inter-observer variability and pave the way for adaptive strategies or stereotactic treatments as external beam pelvic boost in gynecological field.

Identifiants

pubmed: 37711202
doi: 10.3389/fonc.2023.1174675
pmc: PMC10498116
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1174675

Informations de copyright

Copyright © 2023 Titone, Restaino, Moretti, Vullo, Poli, Arcieri, Paglietti, Tonetto, Parisi, Barbui, Trovò, Scambia, Driul and Vizzielli.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Gynecol Cancer. 2016 Jan;26(1):2-30
pubmed: 26645990
Clin Obstet Gynecol. 2011 Jun;54(2):256-65
pubmed: 21508695
J Radiat Res. 2019 Nov 22;60(6):844-848
pubmed: 31665384
Acta Oncol. 2013 Jun;52(5):1010-6
pubmed: 22998475
Int J Gynecol Cancer. 2013 Feb;23(2):385-92
pubmed: 23287959
Br J Radiol. 2016 Dec;89(1068):20160296
pubmed: 27585736
Radiother Oncol. 2021 May;158:1-6
pubmed: 33587973
Acta Biomed. 2019 Dec 23;90(4):405-410
pubmed: 31910163
Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):83-90
pubmed: 23582248
Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):413-424
pubmed: 32905846
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):256-62
pubmed: 21093170

Auteurs

Francesca Titone (F)

Radiation Oncology Unit, Department of Oncology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Stefano Restaino (S)

Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Eugenia Moretti (E)

Medical Physics Unit, Department of Oncology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Gianluca Vullo (G)

Radiation Oncology Unit, Department of Oncology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Alice Poli (A)

Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Department of Medicine, University of Udine, Udine, Italy.

Martina Arcieri (M)

Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Department of Biomedical, Dental, Morphological and Functional Imaging Science, University of Messina, Messina, Italy.

Chiara Paglietti (C)

Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Department of Medicine, University of Udine, Udine, Italy.

Fabrizio Tonetto (F)

Radiation Oncology Unit, Department of Oncology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Giuseppe Parisi (G)

Radiation Oncology Unit, Department of Oncology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Elisa Barbui (E)

Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Marco Trovò (M)

Radiation Oncology Unit, Department of Oncology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Giovanni Scambia (G)

Dipartimento per le Scienze Della Salute Della Donna, del Bambino e di Sanità Pubblica, Unità Operativa Complessa (UOC) Ginecologia Oncologica, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a carattere Scientifico (IRCCS), Rome, Italy.

Lorenza Driul (L)

Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Department of Medicine, University of Udine, Udine, Italy.

Giuseppe Vizzielli (G)

Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Department of Medicine, University of Udine, Udine, Italy.

Classifications MeSH